Friday, October 30, 2026||
MultiKhabarMultiKhabar
Home/finance/Bambusa Therapeutics prices IPO at $16 per share on Nasdaq By Investing.com

Bambusa Therapeutics prices IPO at $16 per share on Nasdaq By Investing.com

In
Investing.com Australia
By Investing.com Australia
10/30/2026, 12:31:57 AM
Share:WhatsAppFacebookX (Twitter)Telegram
EXECUTIVE SUMMARY

Bambusa Therapeutics prices IPO at $16 per share on Nasdaq By Investing.com Investing.com Australia

Key Takeaways

  • Bambusa Therapeutics prices IPO at $16 per share on Nasdaq By Investing.com.

Bambusa Therapeutics prices IPO at $16 per share on Nasdaq By Investing.com  Investing.com Australia

Share:WhatsAppFacebookX (Twitter)Telegram

Read Complete Original Article

Published originally on Investing.com Australia

Visit Publisher Site →
OTHER MEDIA SOURCES COVERING THIS STORY
2 Publishers Reporting
Investing.com
Bambusa Therapeutics prices upsized IPO at $16 per share

Related News

Multikhabar App

All Information In One Place

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!

Get it on Google Play